ABBV vs WST
By Alex · Tickerpine
AbbVie Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | WST |
|---|---|---|
| Price | $285.64 | $392.15 |
| Market cap | $504.76B | $27.60B |
| P/E ratio | 80.5 | 50.1 |
| ROE | — | 19.09% |
| Profit margin | 9.80% | 16.98% |
| Revenue growth | 10.20% | 13.80% |
| Dividend yield | 2.42% | 0.27% |
| Beta | 0.23 | 1.12 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs WST in plain English
- ABBV is the bigger company — about 18.3× the market cap of WST.
- WST is cheaper on earnings (P/E 50.1 vs 80.5).
- WST is growing revenue faster (14% vs 10%).
- ABBV has the higher dividend yield (2.42% vs 0.27%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.